| Primary |
| Cardiac Failure |
25.0% |
| Chronic Myeloid Leukaemia |
25.0% |
| Chronic Obstructive Pulmonary Disease |
25.0% |
| Gastritis |
25.0% |
|
|
| Secondary |
| Product Used For Unknown Indication |
29.0% |
| Premedication |
11.6% |
| Hypertension |
8.7% |
| B-cell Lymphoma |
5.8% |
| Cardiac Failure |
4.3% |
| Cardiomyopathy |
4.3% |
| Chronic Hepatitis C |
4.3% |
| Dyspnoea |
4.3% |
| Feeling Hot |
4.3% |
| Cardiac Failure Congestive |
2.9% |
| Coronary Artery Disease |
2.9% |
| Liver Transplant |
2.9% |
| Prophylaxis |
2.9% |
| Renal Transplant |
2.9% |
| Arterial Disorder |
1.4% |
| Ascites |
1.4% |
| Atrial Fibrillation |
1.4% |
| Epilepsy |
1.4% |
| Hypertonia |
1.4% |
| Hypokalaemia |
1.4% |
|
| Renal Failure Acute |
15.4% |
| Cholestatic Liver Injury |
7.7% |
| Constipation |
7.7% |
| Heart Transplant |
7.7% |
| Hepatic Cirrhosis |
7.7% |
| International Normalised Ratio Increased |
7.7% |
| Pain In Extremity |
7.7% |
| Product Formulation Issue |
7.7% |
| Pulmonary Arterial Pressure Increased |
7.7% |
| Sexual Dysfunction |
7.7% |
| Syncope |
7.7% |
| Ventricular Tachycardia |
7.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.2% |
| Diffuse Large B-cell Lymphoma |
9.0% |
| Hypertension |
8.6% |
| Cardiac Failure |
8.0% |
| Prophylaxis |
7.0% |
| Atrial Fibrillation |
4.4% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Coronary Artery Disease |
3.1% |
| Pulmonary Arterial Hypertension |
3.1% |
| Acute Myeloid Leukaemia |
2.9% |
| Hepatitis C |
2.8% |
| Rheumatoid Arthritis |
2.5% |
| Cerebrovascular Accident Prophylaxis |
2.1% |
| Drug Use For Unknown Indication |
2.0% |
| Depression |
1.8% |
| Oedema |
1.7% |
| Diabetes Mellitus |
1.5% |
| Encephalitis |
1.5% |
| Type 2 Diabetes Mellitus |
1.4% |
| Ascites |
1.2% |
|
| Cardiomyopathy |
9.0% |
| Drug Ineffective |
9.0% |
| Supraventricular Tachycardia |
9.0% |
| Pneumonia |
7.5% |
| Sinusitis |
7.5% |
| Vomiting |
7.5% |
| Injection Site Pain |
6.0% |
| Somnolence |
6.0% |
| Death |
4.5% |
| Laceration |
4.5% |
| Bronchitis |
3.0% |
| Cardiac Failure Congestive |
3.0% |
| Cerebrovascular Accident |
3.0% |
| Eye Haemorrhage |
3.0% |
| Humerus Fracture |
3.0% |
| Malaise |
3.0% |
| Myocardial Infarction |
3.0% |
| Nausea |
3.0% |
| Oedema Due To Cardiac Disease |
3.0% |
| Pericardial Haemorrhage |
3.0% |
|
